Antioxidant activity and protection of pancreatic β-cells by embelin in streptozotocin-induced diabetes.

Department of Zoology, University of Rajasthan, Jaipur, India.
Journal of Diabetes (Impact Factor: 2.94). 01/2012; 4(3):248-56. DOI: 10.1111/j.1753-0407.2012.00187.x
Source: PubMed

ABSTRACT The aim of the present study was to evaluate the antioxidant potential of embelin in streptozotocin-induced diabetes.
  Diabetes was induced in rats fasted overnight by the administration of a single dose of streptozotocin, and analyzed for blood, serum, and biological and histological pancreatic tissue parameters in intact control, diabetic, and embelin-treated diabetic rats (n = 9) at the dose levels of 15, 25, and 30 mg/kg/day for 21 days.
Diabetes caused highly significant abnormalities in blood, serum, and pancreatic tissue biochemical parameters. Embelin and glibenclamide administration to diabetic rats caused a highly significant decline in the blood glycated hemoglobin and serum glucose levels and nitric oxide activity, with a concomitant increase in the serum insulin level (P < 0.001). Furthermore, embelin and glibenclamide treatment increased the pancreatic antioxidant enzyme status (superoxide dismutase, catalase, reduced glutathione, glutathione peroxidase, glutathione S-transferase, and ascorbic acid), and also decreased the thiobarbituric acid reactive oxygen species contents (P < 0.001). The histoarchitecture of the diabetic rats typically showed a degenerated pancreas with reduced β-cell counts, while embelin treatment was shown to significantly regenerate islet cells.
The study proves the potent antioxidant activity of embelin, which has been found to be effective in managing severe hyperglycemia.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Abstract This article reports for the first time the antibacterial, antifungal, antioxidant and anticancer activities of vilangin synthesised from embelin isolated from Embelia ribes berries. E. ribes is widely used as traditional herbal medicine in India. E. ribes is used as appetiser, carminative, anthelmintic, alexiteric, laxative and alterative. This plant is also used to treat tumour, ascites, bronchitis, mental diseases, dyspnoea, heart diseases, urinary discharges, jaundice, hemicrania, and worms in wounds. Here the major compound, embelin, was isolated from the fruits of E. ribes. Vilangin was synthesised by condensation of embelin with formaldehyde in acetic acid solution. The biological activity of vilangin is unknown so far. Hence, we studied antibacterial, antifungal, antioxidant and anticancer activities of vilangin. The minimum inhibitory concentration value of vilangin was 62.5 lg/mL against Staphylococcus epidermidis and Salmonella typhimurium.The radical scavenging activity was maximum at 1,000 lg/mL. Ferric reducing antioxidant power assay of vilangin showed a twofold higher value compared to the standard. Vilangin showed 61.95 % of cytotoxic activity in vitro against A549 lung adenocarcinoma cancer cell line at a dose of 500 lg/mL with half-maximal inhibitory concentration (IC50) of 400 lg/mL. Vilangin can thus be further tested as a new drug. Keywords Antimicrobial � Antioxidant � A549 cancer cell line � Embelia ribes � Embelin � Vilangin.
    Environmental Chemistry Letters 01/2013; · 1.91 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Clinical application of anticancer drugs is limited by problems such as low water solubility, lack of tissue-specificity and toxicity. Formulation development represents an important approach to these problems. Among the many delivery systems studied, polymeric micelles have gained considerable attention owing to ease in preparation, small sizes (10-100 nm), and ability to solubilize water-insoluble anticancer drugs and accumulate specifically at the tumors. This article provides a brief review of several promising micellar systems and their applications in tumor therapy. The emphasis is placed on the discussion of the authors' recent work on several nanomicellar systems that have both a delivery function and antitumor activity, named dual-function drug carriers.
    Therapeutic delivery 01/2014; 5(1):53-68.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Introduction: Embelia ribes or Embelia tsjeriam-cottam, more commonly known as vidanga, is a type of ayurvedic medicine that has been used to treat various diseases for a number of years. Bright orange embelin -rich fruits have been well established as ethnomedicinals, for a number of years with their pharmacological actions attributed to their hydroxybenzoquinone active constituent. Embelin has become known specifically for its antihelminthic and contraceptive use. Areas covered: This drug evaluation provides a historical summary of embelin along with its therapeutic use, phytochemistry and toxicology. Embelin's pharmacotherapeutical properties are also discussed along with its molecular targets. It is hoped that this article will help to draw the attention of researchers and biopharmaceutical companies to the untapped potential in bioprospection for the development of new drugs. Expert opinion: Embelin is the only known non-peptide small-molecule X-linked inhibitor of the apoptosis protein (XIAP) - an anti-apoptotic protein considered a promising cancer therapeutic target. Embelin acts as an NF-κB blocker and potential suppressor of tumorigenesis. It also exhibits potent cytotoxic, antioxidant and cancer chemopreventive effects. Given the potential uses of embelin, it is recommended that further investigations take place to properly explore its pharmacological and clinical effects.
    Expert Opinion on Investigational Drugs 01/2014; · 4.74 Impact Factor